Latest Breaking News On - Nan fung group holdings ltd - Page 6 : comparemela.com

Exscientia (NASDAQ:EXAI) Trading Down 2 6%

Exscientia plc (NASDAQ:EXAI – Get Free Report)’s stock price fell 2.6% during mid-day trading on Tuesday . The company traded as low as $4.45 and last traded at $4.45. 30,025 shares changed hands during trading, a decline of 93% from the average session volume of 416,585 shares. The stock had previously closed at $4.57. Analysts […]

United statesMarshall waceBaillie gifford coMorgan stanleyNan fung group holdings ltdExscientia company profileSoftbank groupBerenberg bankGet free reportCapital managementFung group holdings ltdExscientia dailyNasdaq exai

Oculis Holding AG (NASDAQ:OCS) Given Consensus Recommendation of Buy by Brokerages

Oculis Holding AG (NASDAQ:OCS) Given Consensus Recommendation of Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdLombard odier scmNan fung group holdings ltdBarclays plcOculis holdingGet free reportMarketbeat ratingsLombard odierTrading downGet freeOculis daily

Insider Selling: Entrada Therapeutics, Inc (NASDAQ:TRDA) COO Sells 972 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) COO Nathan J. Dowden sold 972 shares of Entrada Therapeutics stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $13.47, for a total transaction of $13,092.84. Following the sale, the chief operating officer now owns 48,168 shares of the […]

Nathanj dowdenYork mellon corpSecurities exchange commissionNan fung group holdings ltdNorthern trust corpEntrada therapeutics company profileCharles schwab investment management incEntrada therapeutics incVanguard group incEntrada therapeuticsGet free reportExchange commissionNew york mellon corpSchwab investment managementTrust corpEntrada therapeutics daily

Kory James Wentworth Sells 950 Shares of Entrada Therapeutics, Inc (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CFO Kory James Wentworth sold 950 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $13.48, for a total transaction of $12,806.00. Following the completion of the transaction, the chief financial officer now directly owns […]

Kory james wentworthNan fung group holdings ltdYork mellon corpVanguard group incEntrada therapeutics incEntrada therapeutics company profileCharles schwab investment management incNorthern trust corpEntrada therapeuticsGet free reportJames wentworthTherapeutics stock downNew york mellon corpSchwab investment managementTrust corpEntrada therapeutics daily

Cabaletta Bio, Inc (NASDAQ:CABA) Receives Average Recommendation of Buy from Brokerages

Cabaletta Bio, Inc (NASDAQ:CABA) Receives Average Recommendation of Buy from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesGwendolyn binderSecurities exchange commissionCabaletta bio incVr adviserNan fung group holdings ltdAmerican international group incCapital managementCabaletta bioGet free reportExchange commissionFung group holdings ltdAmerican international groupGet freeCabaletta bio daily